Skip to main content
. 2018 Aug 10;57(24):3521–3528. doi: 10.2169/internalmedicine.0990-18

Figure 1.

Figure 1.

Event-free and overall survival according to the treatment group Event-free survival. (a) and overall survival (b) in the 115 patients. 2-year EFS are 50% (UNI) and 32% (PHY), and 2-year OS are 77% (UNI) and 72% (PHY). PHY: physicians’ decision group, UNI: unified dose-attenuation group